Validation of the REMINDER Dementia Risk Reduction Program
Launched by UNIVERSITY OF COIMBRA · Mar 16, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The REMINDER Dementia Risk Reduction Program trial is studying a new approach to help prevent dementia in older adults. The researchers want to see if a special program, which includes activities focused on personal development, cognitive skills, social interaction, and behavior changes, can improve thinking abilities and reduce the risk of developing Alzheimer’s disease. They will compare this program to a control group that receives psychoeducation, which means they will learn about dementia and healthy aging.
To join the study, participants need to be 60 years or older, have a specific score indicating a higher risk for dementia, and have no significant cognitive impairment. They should also be able to participate in the study for 12 weeks and have no serious medical or psychiatric conditions that would interfere. During the trial, participants can expect to take part in various sessions designed to enhance their cognitive abilities and overall well-being. This study is important because it aims to provide evidence for effective strategies to help older adults maintain their cognitive health and potentially prevent dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 60 or older
- • CAIDE dementia risk score \>8
- • Cognitive function: absence of significant cognitive impairment as per the Addenbrooke's Cognitive Examination-REVISED
- • Free of physical disabilities that preclude participation in the study
- • Willing to complete all study-related activities for 12 weeks
- Exclusion Criteria:
- • Mild cognitive impairment or dementia;
- • Presence of any neurological event in their medical history that could compromise actual cognition.
- • Presence of any severe psychiatric disorder (mild depressive and anxiety symptoms meet inclusion criteria).
- • Unability to travel to the site where the sessions will be delivered (if so randomization will be circumscribed between the experimental harm REMINDER online and the control group.
- • Illiteracy
About University Of Coimbra
The University of Coimbra, a prestigious institution in Portugal, is dedicated to advancing medical research and innovation through its clinical trial initiatives. With a strong emphasis on collaborative research and interdisciplinary approaches, the university fosters a robust environment for the development of cutting-edge therapies and interventions. Its clinical trials aim to address critical health challenges, leveraging the expertise of its distinguished faculty and state-of-the-art facilities. Committed to ethical standards and patient welfare, the University of Coimbra plays a pivotal role in translating scientific discoveries into tangible health solutions, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Coimbra, , Portugal
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials